Literature DB >> 24527315

3M Coban 2 Layer Compression Therapy: Intelligent Compression Dynamics to Suit Different Patient Needs.

Jan Schuren1, Stéphanie F Bernatchez2, Joseph Tucker2, Ellen Schnobrich2, Patrick J Parks2.   

Abstract

PROBLEM: Chronic venous insufficiency can lead to recalcitrant leg ulcers. Compression has been shown to be effective in healing these ulcers, but most products are difficult to apply and uncomfortable for patients, leading to inconsistent/ineffective clinical application and poor compliance. In addition, compression presents risks for patients with an ankle-brachial pressure index (ABPI) <0.8 because of the possibility of further compromising the arterial circulation. The ABPI is the ratio of systolic leg blood pressure (taken at ankle) to systolic arm blood pressure (taken above elbow, at brachial artery). This is measured to assess a patient's lower extremity arterial perfusion before initiating compression therapy.1. SOLUTION: Using materials science, two-layer compression systems with controlled compression and a low profile were developed. These materials allow for a more consistent bandage application with better control of the applied compression, and their low profile is compatible with most footwear, increasing patient acceptance and compliance with therapy. The original 3M™ Coban™ 2 Layer Compression System is suited for patients with an ABPI ≥0.8; 3M™ Coban™ 2 Layer Lite Compression System can be used on patients with ABPI ≥0.5. NEW TECHNOLOGY: Both compression systems are composed of two layers that combine to create an inelastic sleeve conforming to the limb contour to provide a consistent proper pressure profile to reduce edema. In addition, they slip significantly less than other compression products and improve patient daily living activities and physical symptoms. INDICATIONS FOR USE: Both compression systems are indicated for patients with venous leg ulcers, lymphedema, and other conditions where compression therapy is appropriate. CAUTION: As with any compression system, caution must be used when mixed venous and arterial disease is present to not induce any damage. These products are not indicated when the ABPI is <0.5.

Entities:  

Year:  2012        PMID: 24527315      PMCID: PMC3839010          DOI: 10.1089/wound.2011.0283

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  4 in total

Review 1.  Compression for venous leg ulcers.

Authors:  N Cullum; E A Nelson; A W Fletcher; T A Sheldon
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Pascal's law and the dynamics of compression therapy: a study on healthy volunteers.

Authors:  J Schuren; K Mohr
Journal:  Int Angiol       Date:  2010-10       Impact factor: 2.789

3.  A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers.

Authors:  Christine J Moffatt; Lynfa Edwards; Mark Collier; Terry Treadwell; Michael Miller; Laura Shafer; Gary Sibbald; Alain Brassard; Andrea McIntosh; Alex Reyzelman; Patricia Price; Stacia Merkel Kraus; Shelley-Ann Walters; Keith Harding
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

Review 4.  Management of leg ulcers.

Authors:  Jonathan Kantor; David J Margolis
Journal:  Semin Cutan Med Surg       Date:  2003-09
  4 in total
  1 in total

1.  The efficacy of different bandaging methods in patients with breast cancer-related lymphedema: A prospective, randomized study.

Authors:  Ayşegül Yaman; Pınar Borman; Adeviye İnanlı; Fatma Kul; Sevilay Karahan
Journal:  Turk J Phys Med Rehabil       Date:  2021-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.